As HK2 was a crucial enzyme involved in glycolysis, inhibiting HK2 would reduce the ATP level in cancer cells (**P < 0.01), then triggered activation of the cellular energy regulator AMP-activated protein kinase (AMPK) [26]. The gene discussed is HK2; the disease is cancer.